Correlation Between Telefonaktiebolaget and Sarepta Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telefonaktiebolaget and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telefonaktiebolaget and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telefonaktiebolaget LM Ericsson and Sarepta Therapeutics, you can compare the effects of market volatilities on Telefonaktiebolaget and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telefonaktiebolaget with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telefonaktiebolaget and Sarepta Therapeutics.

Diversification Opportunities for Telefonaktiebolaget and Sarepta Therapeutics

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Telefonaktiebolaget and Sarepta is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Telefonaktiebolaget LM Ericsso and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Telefonaktiebolaget is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telefonaktiebolaget LM Ericsson are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Telefonaktiebolaget i.e., Telefonaktiebolaget and Sarepta Therapeutics go up and down completely randomly.

Pair Corralation between Telefonaktiebolaget and Sarepta Therapeutics

Assuming the 90 days trading horizon Telefonaktiebolaget LM Ericsson is expected to generate 0.65 times more return on investment than Sarepta Therapeutics. However, Telefonaktiebolaget LM Ericsson is 1.55 times less risky than Sarepta Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  1,282  in Telefonaktiebolaget LM Ericsson on August 28, 2024 and sell it today you would earn a total of  1,034  from holding Telefonaktiebolaget LM Ericsson or generate 80.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy84.42%
ValuesDaily Returns

Telefonaktiebolaget LM Ericsso  vs.  Sarepta Therapeutics

 Performance 
       Timeline  
Telefonaktiebolaget 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Telefonaktiebolaget LM Ericsson are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Telefonaktiebolaget sustained solid returns over the last few months and may actually be approaching a breakup point.
Sarepta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Telefonaktiebolaget and Sarepta Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telefonaktiebolaget and Sarepta Therapeutics

The main advantage of trading using opposite Telefonaktiebolaget and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telefonaktiebolaget position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.
The idea behind Telefonaktiebolaget LM Ericsson and Sarepta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Directory
Find actively traded commodities issued by global exchanges